Magnetic resonance imaging (MRI) allows for the delineation between normal and abnormal tissue on a macroscopic scale, sampling an entire tissue volume three-dimensionally. While MRI is an extremely sensitive tool for detecting tissue abnormalities, association of signal changes with an underlying pathological process is usually not straightforward. In the central nervous system, for example, inflammation, demyelination, axonal damage, gliosis, and neuronal death may all induce similar findings on MRI. As such, interpretation of MRI scans depends on the context, and radiological-histopathological correlation is therefore of the utmost importance. Unfortunately, traditional pathological sectioning of brain tissue is often imprecise and inconsistent, thus complicating the comparison between histology sections and MRI. This article presents novel methodology for accurately sectioning primate brain tissues and thus allowing precise matching between histology and MRI. The detailed protocol described in this article will assist investigators in applying this method, which relies on the creation of 3D printed brain slicers. Slightly modified, it can be easily implemented for brains of other species, including humans.
Introduction
In vivo MRI provides a noninvasive and sensitive measure of tissue integrity at the macroscopic level. Changes in MRI signal intensity seen in vivo are outcome measures in many ongoing clinical trials. 1 While the intensity changes seen via MRI can identify areas of abnormality in the context of the whole brain, they are often not sufficiently specific to differentiate pathological processes. This is especially true of dynamic processes involving multiple pathologies. For example, in multiple sclerosis (MS) or its animal model, experimental autoimmune encephalomyelitis (EAE), inflammation, edema, myelin degradation, axonal destruction, gliosis, and neuronal death overlap. 2, 3 To obtain the necessary specificity regarding the underlying pathology, context must be taken into account, together with knowledge of the histology of the MRI-identified abnormal tissues.
However, even in well-controlled animal experiments, matching histology with in vivo MRI is fundamentally challenging for various reasons. First, the difference in dimensional scales between histology sections and MRI is of several orders of magnitude. 4 Second, for proper comparison, the orientation of MRI slice plane must match the sectioning plane of the brain tissue when cut. Due to the shape of the brain, it is very difficult to make consistently straight and accurate cuts when the brain is sitting on a flat surface. Third, the large size of the brain relative to a potentially small area of interest (lesion, tumor, etc.) creates a "needle-in-a-haystack" scenario for the pathologist processing the tissue. Fourth, even when the target tissue is found, it is commonly processed in such a way as to render virtually impossible an association with the original MRI data. Finally, traditional pathological sectioning of brain tissue is often imprecise and inconsistent, further complicating the comparison between histology sections and MRI images. 
Printing the Brain Slicer Box on the Ultimaker 2 Discussion
The protocol outlined here enables an accurate comparison between MRI and histology sections. The protocol is presented in a unified format that can be applied to brains of humans or small animals, such as marmosets or rodents. Differences specific to large (human) and small (nonhuman primate and rodent) brains are highlighted, and in the accompanying video and figures we demonstrate the application in the marmoset. Although the approach is straightforward, the method requires many steps as well as the use of several types of software. Moreover, several issues potentially affecting the accuracy of this method are important to mention.
The image quality of the in vivo MRI is an important factor. To minimize the disparity in image resolution between MRI and digitalized histology images, the smallest possible MRI voxel size should be used. This concept also applies to the image quality of the postmortem MRI. While the increased acquisition time in postmortem MRI allows much higher image resolution, the preparation can introduce image artifacts such as focal signal dropouts related to air bubbles. These artifacts can obscure areas of the tissue as well as affect its contour. Moreover, the dimensions of the tissue on the postmortem MRI are likely to be affected by the fixation process and duration. While the in vivo to ex vivo MRI match can be closely approximated by utilizing anatomical landmarks in slice geometry setup during acquisition, a non-linear registration would still be necessary to reach a higher degree of accuracy in matching those two MRI images.
The design of the brain holder and slicer is also a crucial step. In creating the digital model of the brain, a smoothing algorithm is applied that slightly enlarges the model relative to the fixed brain. This enables easy insertion of the brain into its holder and slicer and reduces sharp edges in the holder's contour. However, if the model is too large (e.g., by more than 5%), the brain might move the sectioning. Another important point is to adapt the design of the brain model so that the cerebellum is properly placed inside the 3D printed object. This can be particularly challenging when the cerebellum has been damaged during the brain extraction at autopsy.
When printing the brain slicer and holder, the type of 3D printer must also be chosen carefully. Some multi-jet printers require post-processing using an oven to remove support material. While these printers can produce objects that are watertight and relatively more durable than desktop fused deposition modeling (FDM) printers, the heating process to remove supports can slightly warp the box, creating blade gaps that are not perfectly perpendicular to the brain contour.
The brain sectioning process is another crucial step. Before cutting the whole brain into slabs, it is important to make sure that the brain is sitting tightly inside the brain slicer: there should be no motion when slight pressure is applied onto the brain. This will make it possible for the blades to cut through the brain at the precise location set by the investigators. A continuous, balanced pressure should be applied to both blade holders when cutting. Depending on the sharpness of the blades and the rigidity of the tissue, a slight transverse cutting motion could be advantageous for maintaining flat cut surfaces.
The paraffin-embedding process can also be a source of misalignment between MRI and histology. If the tissue slab is not sitting flat against the cassette during the embedding process, there will be a tilt between the cutting plane of the microtome and the surface place of the slab. This will require cutting unusable sections to find a flat plane in which all the tissue is exposed. One way to correct for the tilt is by changing the angle of the viewing plane on the high-isotropic-resolution postmortem MRI. However, this is nearly impossible to perform on the in vivo MRI that is usually acquired with anisotropic resolution (typically thick coronal slices).
Finally, the tissue can experience some deformation during the formalin fixation period and paraffin embedding (shrinkage), as well as during the preparation of slides (folding, cracking, wrinkles). Some of these deformations can be corrected by putting the 4-5 μm sections in a water bath before transferring onto slides. Other deformations can be partially solved by performing deformable image coregistration of the histological digitized images to the postmortem MRI images. Nevertheless, minimizing the deformations with careful and skilled practice is the most effective approach to matching MRI volumes to histology sections.
In conclusion, the methodology introduced here enables investigators to accurately assess the underlying pathology of MRI findings. More generally, it is a promising approach for identifying and/or validating novel MRI biomarkers for research studies that target specific pathological processes, such as inflammation or remyelination.
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